Products
Investing
Resources
Support
Bafna Pharmaceuticals Limited (BAFNAPH)
₹79.88
INR+5.86(+7.92%)
As of April 30, 2025 9:29:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹189.13 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹208.00 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
43.93
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
-1.25
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
1.28
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
28.81%
Operating Margin
Operating income as a percentage of revenue
4.23%
Return on Equity
Net income as a percentage of shareholders' equity
9.09%
Revenue (TTM)
Total revenue over trailing 12 months
₹148.20 Cr+16.7%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹12.83 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹1.82+16.6843633755476%
Balance Sheet
Total Cash
Total cash and short-term investments
₹1.31 Cr
Total Debt
Total short-term and long-term debt
₹18.82 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
22.75%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹69 - ₹113
Beta
Measure of stock's volatility compared to the market
0.47
Shares Outstanding
Total number of shares issued by the company
₹2.37 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
NA
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
NA